| Similar Articles |
|---|
 |
Chemistry World
July 2007
Lisa Melton |
There's More to Quitting Than Nicotine As England joins the growing list of nations to ban smoking in enclosed public places, this article explores the medicinal arsenal that could help to kick the habit   |
The Motley Fool
July 30, 2007
Brian Orelli |
Glaxo Puffs Up Targacept In the weird world of drug partnerships, GlaxoSmithKline, maker of antismoking nicotine patches, is teaming up with Targacept to investigate the positive effects of nicotine. Investors, take note. |
Chemistry World
July 12, 2012 |
Drawing on drugs to kick the habit While pharma companies stand accused of giving up on drugs to help people stop smoking, tobacco firms are looking at controversial nicotine replacement products. Anthony King surveys an area that is problematic on all sides. |
Reactive Reports
Issue 58 |
Drug Discovery at a Snail's Pace Researchers isolated a toxin from the venomous cone sea snail. This nerve poison latches on to brain receptors and its chemical structure could be used to design new drugs that interact with these receptors and treat psychiatric and brain diseases. |
Nursing
April 2008
Kathryn Murphy |
Shedding the burden of depression & anxiety Learn about types of depression and available treatments. |
American Family Physician
January 1, 2007
Shashi & Subhash Bhatia |
Childhood and Adolescent Depression Safe and effective treatment of major depression in this age group requires accurate diagnosis, suicide risk assessment, and use of evidence-based therapies. |
Chemistry World
April 12, 2011
Meera Senthilingam |
How antidepressants spur brain growth Researchers have identified the mechanism by which some antidepressants stimulate the formation of new brain cells, an insight that could lead to improved drugs. |
Nurse Practitioner
April 2012
Chaney & Sheriff |
Evidence-based treatments for smoking cessation Smoking addiction is both physical and mental. The etiology of tobacco dependence is multidimensional and includes physiological, psychological, and social/behavioral factors. |
The Motley Fool
March 19, 2007
Michael P. Cecil |
Pfizer's Newest Blockbuster? Will Chantix help Pfizer cure its ailing stock price? |
BusinessWeek
January 17, 2005
Catherine Arnst |
No Pain, Some Gain The 50 million Americans suffering from chronic pain got a little bit of good news in December. The Food & Drug Administration greenlighted two new medications that attack pain in completely novel ways. |
Chemistry World
July 9, 2007
Emma Baines |
Smoking Cessation Drug Shows Promise for Alcohol Dependency A drug recently licensed as an aid to smoking cessation could also be used to treat alcohol addiction, US researchers have found. |
Chemistry World
July 11, 2008
Manisha Lalloo |
Side-effects study opens up new drug leads Existing drugs could be used to treat a broader range of diseases, according to scientists in Germany and Denmark, who have predicted drug targets by using side-effects data on medication labels. |
The Motley Fool
February 4, 2008
Brian Lawler |
Disenchanted With Chantix The FDA issues a health advisory for Chantix, Pfizer's new non-nicotine stop-smoking treatment. |
The Motley Fool
March 14, 2008
Brian Orelli |
Weighing In on Obesity Drugs Could investing in drugmakers that produce weight-loss drugs help fatten your wallet? |
Chemistry World
July 2, 2013
Jeanne Therese Andres |
Mapping receptors in the brain Scientists from the UK and Germany have developed new compounds that target and bind to brain proteins linked to serious neurological disorders. |
The Motley Fool
May 18, 2011
Frank Vinluan |
Targacept's $75M Stock Offering Targets Cognitive Disorders R&D AstraZeneca bailed, but Targacept keeps on trucking. |
Chemistry World
August 24, 2015
Rebecca Trager |
New drug treatment for alcoholism shows promise in animal studies Beta-carbolines developed by researchers at the University of Wisconsin in Milwaukee, US, could offer a novel treatment for alcoholism that targets a specific receptor in the brain, rather than simply reducing dopamine levels. |
Chemistry World
January 31, 2007
Victoria Gill |
LSD reveals its secrets A long-standing pharmacological mystery surrounding hallucinogens may finally have been solved by a new study. |
Chemistry World
December 9, 2013
James Urquhart |
Drug fix for misfolded proteins promises hope for incurable diseases Researchers have been looking into pharmacological chaperones or pharmacoperones. They might treat diseases brought about by genetic mutations that cause otherwise functional proteins to become misfolded or misrouted. |
HHMI Bulletin
February 2011
Sarah C.P. Williams |
Forgetting Fear A compound given at just the right time may make mice forget to be afraid. |
The Motley Fool
December 4, 2009
Brian Orelli |
After Rising 500%, What Did You Expect? A nice licensing deal, but the stock was too high to begin with. The development-stage drugmaker Targacept licensed its lead product, depression treatment TC-5214, to AstraZeneca yesterday. |
The Motley Fool
January 8, 2010
Brian Orelli |
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands. |
Chemistry World
October 25, 2007 |
Elusive Drug Target Finally Seen Scientists have captured an atomic-scale picture of a receptor protein from a family that is the target of thousands of drugs. |
Chemistry World
July 21, 2011
Elinor Richards |
Cell Control to Change Cell Function US scientists can now control the reactions occurring inside cells. |
Chemistry World
January 13, 2008
Ananyo Bhattacharya |
Unexpected Effects of Drug Combinations Medicines that use a combination of several drugs can sometimes produce unexpected effects in patients. Now, a team of scientists think they have figured out how that can happen. |
Managed Care
May 2004
Thomas Morrow |
New Agents Regulating Tyrosine Kinase Can Be Used Against Several Cancers When traditional therapies fail in cancer treatment, turning off a chemical switch may offer hope to the hopeless. |
Reactive Reports
Apr/May 2005
David Bradley |
Of Mice and Women Mice lacking a molecule usually found on the surface of cells in the womb have fertility problems, according to a study by researchers. |
The Motley Fool
December 4, 2006
Michael Leibert |
Whither Pfizer? Bad news follows the upbeat message delivered at Pfizer's R&D briefing. But with strong cash flows, a healthy dividend yield, unparalleled scale, and a discounted share price, Pfizer's risk/reward profile might look attractive to investors. |
Chemistry World
February 12, 2009
Simon Hadlington |
Mystery receptor's binding partner uncovered For decades scientists have puzzled over the role of the sigma-1 receptor, a protein found in almost all mammalian cells, including the nervous system. |
